Google Finance provides a snapshot of Hansen Medical’s (formerly ticker: HNSN, now part of Auris Health, Inc.) historical stock information, news, and relevant financial data. However, it’s crucial to remember that Hansen Medical is no longer a publicly traded entity. Therefore, the data presented on Google Finance primarily pertains to its past performance before its acquisition. Hansen Medical was a medical robotics company specializing in developing robotic systems for precise catheter placement during minimally invasive procedures. Their flagship products were the Sensei® Robotic System and the Magellan™ Robotic System. The Sensei system was primarily used for electrophysiology procedures, allowing physicians to remotely control catheters within the heart to treat arrhythmias. The Magellan system expanded the application of robotic assistance to peripheral vasculature, enabling access to complex anatomical areas during endovascular procedures. Reviewing Hansen Medical’s historical data on Google Finance reveals key trends in its stock performance. One would likely observe periods of high volatility influenced by clinical trial results, regulatory approvals (or denials), and competitive pressures within the medical device market. News articles archived on the platform can shed light on significant events impacting the company, such as product launches, partnerships, and financial reports. Analyzing the financial data, such as revenue, net income, and cash flow, provides insight into Hansen Medical’s operational performance over time. Keep in mind that this information is retrospective and doesn’t reflect the current financial status of Auris Health, Inc., or Johnson & Johnson, who ultimately acquired Auris Health. Examining trends in these metrics can help understand the challenges and opportunities Hansen Medical faced as an independent company. For example, understanding their research and development expenses in relation to revenue can offer clues to the company’s commitment to innovation and future growth potential. One key aspect revealed by Google Finance, and its associated news articles, is the eventual acquisition of Hansen Medical. Johnson & Johnson acquired Auris Health, Inc. in 2019 for $3.4 billion. Auris Health had, in turn, acquired Hansen Medical prior to this. The acquisition highlighted the strategic value of Hansen Medical’s robotic technology within the broader medical device landscape. The technology developed by Hansen Medical was eventually integrated into Johnson & Johnson’s surgical robotics platform, marking a significant advancement in minimally invasive surgical techniques. While Google Finance provides a valuable historical record of Hansen Medical’s performance as a publicly traded company, it’s important to recognize its limitations. The information is dated and does not reflect the current state of the technology or its integration within Johnson & Johnson. Furthermore, relying solely on Google Finance might not offer a complete picture of the company’s technological advancements or clinical impact after its acquisition. For comprehensive insights into the current application of robotic technologies stemming from Hansen Medical, researching Johnson & Johnson’s surgical robotics division and relevant publications in the medical field is necessary.